MyAverix Finance
TWO · Healthcare
Intech Biopharm Ltd (6461)
Biotechnology
Intech Biopharm Ltd (6461) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 6461
Intech Biopharm Ltd (6461) — FAQ
What is 6461's P/E ratio?
The price-to-earnings (P/E) ratio for Intech Biopharm Ltd (6461) is 25.00 (data as of 2026-05-23).
Does Intech Biopharm Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Intech Biopharm Ltd (6461). Check the MyAverix Finance app for the latest dividend data.
What sector is Intech Biopharm Ltd in?
Intech Biopharm Ltd (6461) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 6461 listed on?
6461 is listed on TWO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.